Live News EQUITY L impact Jul 27, 2026, 11:18 AM UTC

MPLT (more) Maplight Therapeutics Inc - 330/6 mg once-daily (qd) dose did not achieve statistical significance on primary endpoint

MPLT (more) Maplight Therapeutics Inc - 330/6 mg once-daily (qd) dose did not achieve statistical significance on primary endpoint

SquawkNews Newsroom

MPLT (more) Maplight Therapeutics Inc - 330/6 mg once-daily (qd) dose did not achieve statistical significance on primary endpoint